Oncolytic bacteria therapy for malignant glioma. [PDF]
Li F, Zhao J, Ji A, Zhao J, Li S.
europepmc +1 more source
Treatment of hypertrophic scars using fractional CO2 laser alone in comparison with adding botulinium toxin either intalesional injection or assisted drug delivery. [PDF]
Fahim A, Saied E, El-Mesidy MS.
europepmc +1 more source
The impact of TcdB conformational dynamics on vaccination against Clostridioides difficile. [PDF]
Kempher ML +8 more
europepmc +1 more source
Multimodal Approach for Lower Leg Liposculpture: A Case Series and Lessons Learned. [PDF]
Copeland-Halperin LR +2 more
europepmc +1 more source
Influence of Periorbital Dynamic Rhytides on Surgical Outcomes of Lower Eyelid Blepharoplasty: A Clinical Efficacy Assessment. [PDF]
Liu C +5 more
europepmc +1 more source
A Diagnostic Challenge: Necrotizing Retropharyngeal Lymphadenitis With Microbiologically Supported Multifocal Pseudomonas aeruginosa Infection and a Tularemia-Like Presentation. [PDF]
AlKadhem SM +5 more
europepmc +1 more source
Cellular and systemic effects of anthrax lethal toxin and edema toxin [PDF]
Anthrax lethal toxin (LT) and edema toxin (ET) are the major virulence factors of anthrax and can replicate the lethality and symptoms associated with the disease. This review provides an overview of our current understanding of anthrax toxin effects in animal models and the cytotoxicity (necrosis and apoptosis) induced by LT in different cells.
Stephen H. Leppla, Mahtab Moayeri
exaly +3 more sources
Anthrax lethal and edema toxins in anthrax pathogenesis [PDF]
The pathophysiological effects resulting from many bacterial diseases are caused by exotoxins released by the bacteria. Bacillus anthracis, a spore-forming bacterium, is such a pathogen, causing anthrax through a combination of bacterial infection and toxemia. B.
Stephen H. Leppla +2 more
exaly +3 more sources

